Related Experiment Video
Updated: Nov 1, 2025

09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
9.0K
Disulfide-containing Macromolecules for Therapeutic Delivery.
Ziwen Jiang1, S Thayumanavan1,2,3
1Department of Chemistry, University of Massachusetts Amherst, Massachusetts 01003, United States.
Israel Journal of Chemistry
|June 25, 2021
Summary
Synthetic polymers with disulfide bonds are key for drug delivery. This overview explores their design and the role of disulfide bonds in advanced therapeutic systems.
Area of Science:
- Polymer Chemistry
- Biomaterials Science
- Drug Delivery Systems
Background:
- Macromolecules serve as essential platforms for therapeutic delivery.
- Synthetic polymers offer tunable properties for advanced applications.
- Disulfide bonds are crucial functional groups in polymer design.
Purpose of the Study:
- To provide an overview of synthetic polymer design principles for therapeutic delivery.
- To highlight the role of disulfide bonds in polymer architecture (backbone or side chains).
- To identify current knowledge gaps and future research directions regarding disulfide bonds in drug delivery.
Main Methods:
- Review of design principles for synthetic polymers incorporating disulfide bonds.
- Analysis of the functional role of disulfide bonds in polymer structure and performance.
- Discussion of existing literature and identification of unanswered questions.
Main Results:
- Synthetic polymers with disulfide bonds can be designed with specific architectures.
- Disulfide bonds influence polymer properties relevant to drug release and targeting.
- Several questions remain regarding the optimization and application of these systems.
Conclusions:
- Synthetic polymers with disulfide bonds represent a promising platform for drug delivery.
- Further research is needed to fully elucidate the potential of disulfide bonds in therapeutic systems.
- Understanding design principles is critical for advancing therapeutic delivery technologies.
Related Concept Videos
Structure and Nomenclature of Thiols and Sulfides
5.2K
Thiols and sulfides are sulfur analogs of alcohols and ethers, respectively, where the sulfur atom takes the place of the oxygen atom. Thus, thiols are generally represented as RSH, where R is an alkyl substituent and —SH is the functional group. On the other hand, in sulfides, the central sulfur atom is bonded to two hydrocarbon groups on either side. Depending upon the type of group, sulfides can be either symmetrical or asymmetrical. Both thiols and sulfides display a bent geometry,...
5.2K
Preparation and Reactions of Thiols
6.9K
Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
6.9K
Preparation and Reactions of Sulfides
5.3K
Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
5.3K
Sulfur Assimilation
144
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
144
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
596
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
596

